Endpoints News 生物医药· Lei Lei Wu·· 2 天前AI 评分43
Sellas 公司癌症疫苗在 AML 患者 III 期试验中取得成功
Sellas claims Phase 3 win on AML cancer vaccine
AI 导读
Sellas Life Sciences 公司宣布,其癌症疫苗在急性髓系白血病(AML)患者的 III 期临床试验中取得成功。公司称该疫苗对特定 AML 患者有效,相关结果于本周二公布。
正文
Sellas Life Sciences’ cancer vaccine succeeded in a Phase 3 trial of certain acute myeloid leukemia patients, the company said Tuesday.
…
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
来源:Endpoints News 生物医药 · endpoints.news